MASTEC INC (MTZ) Fundamental Analysis & Valuation

NYSE:MTZ • US5763231090

Current stock price

336.25 USD
+2.46 (+0.74%)
At close:
340.28 USD
+4.03 (+1.2%)
Pre-Market:

This MTZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MTZ Profitability Analysis

1.1 Basic Checks

  • MTZ had positive earnings in the past year.
  • MTZ had a positive operating cash flow in the past year.
  • Of the past 5 years MTZ 4 years were profitable.
  • MTZ had a positive operating cash flow in each of the past 5 years.
MTZ Yearly Net Income VS EBIT VS OCF VS FCFMTZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • MTZ has a Return On Assets of 4.02%. This is comparable to the rest of the industry: MTZ outperforms 55.36% of its industry peers.
  • With a Return On Equity value of 12.24%, MTZ perfoms like the industry average, outperforming 55.36% of the companies in the same industry.
  • MTZ's Return On Invested Capital of 8.01% is fine compared to the rest of the industry. MTZ outperforms 60.71% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MTZ is significantly below the industry average of 17.34%.
  • The 3 year average ROIC (5.53%) for MTZ is below the current ROIC(8.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.02%
ROE 12.24%
ROIC 8.01%
ROA(3y)1.77%
ROA(5y)2.06%
ROE(3y)5.33%
ROE(5y)6.03%
ROIC(3y)5.53%
ROIC(5y)5.54%
MTZ Yearly ROA, ROE, ROICMTZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • MTZ has a Profit Margin (2.79%) which is comparable to the rest of the industry.
  • MTZ's Profit Margin has declined in the last couple of years.
  • MTZ has a Operating Margin (4.62%) which is in line with its industry peers.
  • MTZ's Operating Margin has declined in the last couple of years.
  • MTZ has a Gross Margin of 12.54%. This is in the lower half of the industry: MTZ underperforms 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of MTZ has declined.
Industry RankSector Rank
OM 4.62%
PM (TTM) 2.79%
GM 12.54%
OM growth 3Y11.88%
OM growth 5Y-8.68%
PM growth 3Y101.41%
PM growth 5Y-11.38%
GM growth 3Y0.95%
GM growth 5Y-5.47%
MTZ Yearly Profit, Operating, Gross MarginsMTZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MTZ Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MTZ is destroying value.
  • The number of shares outstanding for MTZ has been reduced compared to 1 year ago.
  • The number of shares outstanding for MTZ has been increased compared to 5 years ago.
  • MTZ has a better debt/assets ratio than last year.
MTZ Yearly Shares OutstandingMTZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MTZ Yearly Total Debt VS Total AssetsMTZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • MTZ has an Altman-Z score of 4.56. This indicates that MTZ is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.56, MTZ is doing good in the industry, outperforming 67.86% of the companies in the same industry.
  • MTZ has a debt to FCF ratio of 8.16. This is a slightly negative value and a sign of low solvency as MTZ would need 8.16 years to pay back of all of its debts.
  • MTZ has a Debt to FCF ratio (8.16) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that MTZ is somewhat dependend on debt financing.
  • MTZ has a Debt to Equity ratio (0.67) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 8.16
Altman-Z 4.56
ROIC/WACC0.8
WACC10.07%
MTZ Yearly LT Debt VS Equity VS FCFMTZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • MTZ has a Current Ratio of 1.32. This is a normal value and indicates that MTZ is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, MTZ is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
  • A Quick Ratio of 1.29 indicates that MTZ should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.29, MTZ is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.29
MTZ Yearly Current Assets VS Current LiabilitesMTZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. MTZ Growth Analysis

3.1 Past

  • MTZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.95%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 5.01% on average over the past years.
  • MTZ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.22%.
  • Measured over the past years, MTZ shows a quite strong growth in Revenue. The Revenue has been growing by 17.73% on average per year.
EPS 1Y (TTM)67.95%
EPS 3Y28.74%
EPS 5Y5.01%
EPS Q2Q%43.75%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y13.51%
Revenue growth 5Y17.73%
Sales Q2Q%15.77%

3.2 Future

  • Based on estimates for the next years, MTZ will show a very strong growth in Earnings Per Share. The EPS will grow by 22.16% on average per year.
  • MTZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.30% yearly.
EPS Next Y29%
EPS Next 2Y24.65%
EPS Next 3Y24.75%
EPS Next 5Y22.16%
Revenue Next Year21.13%
Revenue Next 2Y15.44%
Revenue Next 3Y13.49%
Revenue Next 5Y10.3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MTZ Yearly Revenue VS EstimatesMTZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
MTZ Yearly EPS VS EstimatesMTZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

2

4. MTZ Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 51.34 indicates a quite expensive valuation of MTZ.
  • The rest of the industry has a similar Price/Earnings ratio as MTZ.
  • MTZ's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.17.
  • MTZ is valuated quite expensively with a Price/Forward Earnings ratio of 39.80.
  • MTZ's Price/Forward Earnings is on the same level as the industry average.
  • MTZ is valuated expensively when we compare the Price/Forward Earnings ratio to 23.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 51.34
Fwd PE 39.8
MTZ Price Earnings VS Forward Price EarningsMTZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • MTZ's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as MTZ.
Industry RankSector Rank
P/FCF 92.84
EV/EBITDA 26.17
MTZ Per share dataMTZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as MTZ's earnings are expected to grow with 24.75% in the coming years.
PEG (NY)1.77
PEG (5Y)10.25
EPS Next 2Y24.65%
EPS Next 3Y24.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MTZ Dividend Analysis

5.1 Amount

  • MTZ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MTZ Fundamentals: All Metrics, Ratios and Statistics

MASTEC INC

NYSE:MTZ (4/2/2026, 8:04:00 PM)

Premarket: 340.28 +4.03 (+1.2%)

336.25

+2.46 (+0.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners76.07%
Inst Owner Change0%
Ins Owners21.42%
Ins Owner Change-0.03%
Market Cap26.53B
Revenue(TTM)14.30B
Net Income(TTM)399.04M
Analysts83.08
Price Target340.5 (1.26%)
Short Float %4.15%
Short Ratio2.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.99%
Min EPS beat(2)5.34%
Max EPS beat(2)6.65%
EPS beat(4)4
Avg EPS beat(4)16.73%
Min EPS beat(4)5.34%
Max EPS beat(4)49.47%
EPS beat(8)8
Avg EPS beat(8)24.65%
EPS beat(12)11
Avg EPS beat(12)17.2%
EPS beat(16)15
Avg EPS beat(16)18%
Revenue beat(2)2
Avg Revenue beat(2)2.85%
Min Revenue beat(2)0.63%
Max Revenue beat(2)5.06%
Revenue beat(4)4
Avg Revenue beat(4)3.21%
Min Revenue beat(4)0.63%
Max Revenue beat(4)5.06%
Revenue beat(8)6
Avg Revenue beat(8)0.58%
Revenue beat(12)7
Avg Revenue beat(12)-0.6%
Revenue beat(16)10
Avg Revenue beat(16)0.16%
PT rev (1m)29.28%
PT rev (3m)33.05%
EPS NQ rev (1m)1.53%
EPS NQ rev (3m)8.48%
EPS NY rev (1m)0%
EPS NY rev (3m)2.47%
Revenue NQ rev (1m)3.4%
Revenue NQ rev (3m)7.8%
Revenue NY rev (1m)5.23%
Revenue NY rev (3m)9.92%
Valuation
Industry RankSector Rank
PE 51.34
Fwd PE 39.8
P/S 1.86
P/FCF 92.84
P/OCF 48.61
P/B 8.14
P/tB 74.92
EV/EBITDA 26.17
EPS(TTM)6.55
EY1.95%
EPS(NY)8.45
Fwd EY2.51%
FCF(TTM)3.62
FCFY1.08%
OCF(TTM)6.92
OCFY2.06%
SpS181.25
BVpS41.31
TBVpS4.49
PEG (NY)1.77
PEG (5Y)10.25
Graham Number78.03
Profitability
Industry RankSector Rank
ROA 4.02%
ROE 12.24%
ROCE 9.93%
ROIC 8.01%
ROICexc 8.52%
ROICexgc 15.9%
OM 4.62%
PM (TTM) 2.79%
GM 12.54%
FCFM 2%
ROA(3y)1.77%
ROA(5y)2.06%
ROE(3y)5.33%
ROE(5y)6.03%
ROIC(3y)5.53%
ROIC(5y)5.54%
ROICexc(3y)5.91%
ROICexc(5y)5.92%
ROICexgc(3y)11.65%
ROICexgc(5y)11.3%
ROCE(3y)6.85%
ROCE(5y)6.87%
ROICexgc growth 3Y28.04%
ROICexgc growth 5Y-3.4%
ROICexc growth 3Y28.13%
ROICexc growth 5Y-4.89%
OM growth 3Y11.88%
OM growth 5Y-8.68%
PM growth 3Y101.41%
PM growth 5Y-11.38%
GM growth 3Y0.95%
GM growth 5Y-5.47%
F-Score8
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 8.16
Debt/EBITDA 2
Cap/Depr 60.87%
Cap/Sales 1.82%
Interest Coverage 3.74
Cash Conversion 50.18%
Profit Quality 71.6%
Current Ratio 1.32
Quick Ratio 1.29
Altman-Z 4.56
F-Score8
WACC10.07%
ROIC/WACC0.8
Cap/Depr(3y)40.75%
Cap/Depr(5y)42.88%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.95%
EPS 3Y28.74%
EPS 5Y5.01%
EPS Q2Q%43.75%
EPS Next Y29%
EPS Next 2Y24.65%
EPS Next 3Y24.75%
EPS Next 5Y22.16%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y13.51%
Revenue growth 5Y17.73%
Sales Q2Q%15.77%
Revenue Next Year21.13%
Revenue Next 2Y15.44%
Revenue Next 3Y13.49%
Revenue Next 5Y10.3%
EBIT growth 1Y35.6%
EBIT growth 3Y26.99%
EBIT growth 5Y7.51%
EBIT Next Year106.02%
EBIT Next 3Y40.12%
EBIT Next 5Y28.7%
FCF growth 1Y-70.63%
FCF growth 3Y47.58%
FCF growth 5Y-16.96%
OCF growth 1Y-51.35%
OCF growth 3Y15.7%
OCF growth 5Y-10.25%

MASTEC INC / MTZ Fundamental Analysis FAQ

What is the fundamental rating for MTZ stock?

ChartMill assigns a fundamental rating of 4 / 10 to MTZ.


What is the valuation status for MTZ stock?

ChartMill assigns a valuation rating of 2 / 10 to MASTEC INC (MTZ). This can be considered as Overvalued.


How profitable is MASTEC INC (MTZ) stock?

MASTEC INC (MTZ) has a profitability rating of 4 / 10.


How financially healthy is MASTEC INC?

The financial health rating of MASTEC INC (MTZ) is 5 / 10.